https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35616 Wed 18 Sep 2019 09:38:38 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16814 Wed 11 Apr 2018 13:49:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14767 Wed 11 Apr 2018 10:55:28 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18845 Wed 11 Apr 2018 09:50:44 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39865 Tue 28 Jun 2022 14:19:00 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44281 Tue 11 Oct 2022 14:41:34 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45390 Thu 27 Oct 2022 15:02:21 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45037 Thu 27 Oct 2022 12:11:07 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40132 Thu 14 Jul 2022 11:33:12 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9405 12 on the EPDS and/or positive on the “interval symptom” question were then administered the CIDI. A further 65 randomly selected women that screened negative were also administered the CIDI. Loss to postnatal follow-up was very significant, and returns rates were inconsistent across the three postnatal time points. Almost 25% of those who screened positive did not complete a CIDI. For screen-positive status, a total of 314 (24.4%) of those that returned questionnaires (N=1,289) screened positive at least once across the 6- to 8-month interval. Of these, 79 were lost to follow-up; thus, 235 (74.8%) completed a CIDI. In this group, 34.7% had been positive both on the EPDS and the “interval” question, 15.9% on the EPDS alone, and 49.4% on the “interval” question alone. For the CIDI diagnosis and estimated 6- to 8-month period CIDI prevalence, among those 235 women who screened positive and completed a CIDI, 67.2% met the criteria for a CIDI diagnosis, as did 16.9% of those who screened negative. The breakdown in CIDI diagnoses in the 235 women was 32.8% major depression (± anxiety disorder); 26.4% minor depression alone; and 8.1% with a primary anxiety disorder (approximately half with minor depression). Put another way, 20.4% of these women had an anxiety disorder (approximately two thirds with comorbid depression) and 37.7% of women with a major depressive episode (MDE) had a comorbid anxiety disorder. The estimated 6- to 8-month prevalence rate for a CIDI diagnosis of anxiety or depression (major or minor) was 29.2% (95% CI 26.7%–31.7%). The use of the “interval symptom” question alone was 1.7 times more likely to identify positive CIDI cases than the EPDS alone. Almost 40% of postnatal women with a diagnosis of MDE have a comorbid diagnosis of anxiety disorder. The estimated 6- to 8-month period prevalence for CIDI cases of anxiety and depression was 29.2%. Screening for anxiety and depression using the EPDS alone was associated with a lesser capacity to identify CIDI caseness than a simple “interval symptom” question (for the 2 months prior) which almost doubled the yield. This paper demonstrates that combining the EPDS with the “interval symptom” question improves detection of CIDI caseness.]]> Sat 24 Mar 2018 08:39:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15353 Sat 24 Mar 2018 08:25:43 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44732 Mon 24 Oct 2022 08:28:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40153 Fri 15 Jul 2022 09:57:22 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49169 Fri 05 May 2023 15:37:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38179 Fri 03 Sep 2021 14:50:35 AEST ]]>